SCHEMBL5598322

SCHEMBL5598322

CCCCCCC1COC(=O)O1

nearest known ligand 0.54

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.54
ALDH1A1 P00352 1/20 0.53
PPARG P37231 2/20 0.48
EPHX1 P07099 1/20 0.46
GRM2 Q14416 10/20 0.43
SIRT2 Q8IXJ6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8518471 1.00 CYP1A2 (0.54) CYP1A2ALDH1A1PPARGEPHX1GRM2
SCHEMBL9576975 1.00 CYP1A2 (0.54) CYP1A2ALDH1A1PPARGEPHX1GRM2
SCHEMBL19283429 1.00 CYP1A2 (0.54) CYP1A2ALDH1A1PPARGEPHX1GRM2
SCHEMBL17265372 1.00 CYP1A2 (0.54) CYP1A2ALDH1A1PPARGEPHX1GRM2
SCHEMBL13058166 1.00 CYP1A2 (0.54) CYP1A2ALDH1A1PPARGEPHX1GRM2
SCHEMBL2272354 0.98 CYP1A2 (0.51) CYP1A2ALDH1A1PPARGEPHX1GRM2
SCHEMBL29065659 0.93 CYP1A2 (0.49) CYP1A2ALDH1A1PPARGEPHX1GRM2
SCHEMBL2344886 0.92 CYP1A2 (0.44) CYP1A2ALDH1A1PPARGEPHX1GRM2
SCHEMBL14539537 0.92 CYP1A2 (0.44) CYP1A2ALDH1A1PPARGEPHX1GRM2
SCHEMBL17227787 0.90 CYP1A2 (0.40) CYP1A2ALDH1A1PPARGEPHX1GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12107222-B2 Liquid electrolyte comprising organic carbonates and cyclic sulfoxides for applications in lithium secondary batteries FORSCHUNGSZENTRUM JUELICH GMBH (DE) 2024-10-01 US claimed
US-20210313623-A1 LIQUID ELECTROLYTE COMPRISING ORGANIC CARBONATES AND CYCLIC SULFOXIDES FOR APPLICATIONS IN LITHIUM SECONDARY BATTERIES FORSCHUNGSZENTRUM JUELICH GMBH (DE) 2021-10-07 US claimed
EP-3834246-A1 LIQUID ELECTROLYTE COMPRISING ORGANIC CARBONATES AND CYCLIC SULFOXIDES FOR APPLICATIONS IN LITHIUM SECONDARY BATTERIES Forschungszentrum Jülich GmbH (DE) 2021-06-16 EP claimed
CN-112585794-A Liquid electrolyte comprising organic carbonate and cyclic sulfoxide for use in lithium secondary battery 于利奇研究中心有限公司 2021-03-30 CN claimed
EP-2903974-B1 ONE STEP PROCESS FOR SYNTHESIS OF CYCLIC CARBONATES COUNCIL OF SCIENT & IND RES AN INDIAN REGISTERED BODY INC UNDER THE REGISTRATION OF SOCIETIES ACT AC (IN) 2016-11-23 EP claimed
US-9266854-B2 One step process for synthesis of cyclic carbonates COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-02-23 US claimed
US-20150259318-A1 ONE STEP PROCESS FOR SYNTHESIS OF CYCLIC CARBONATES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-09-17 US claimed
EP-2903974-A1 ONE STEP PROCESS FOR SYNTHESIS OF CYCLIC CARBONATES Council of Scientific & Industrial Research An Indian registered body incorporated under the Registration of Societies Act (Act XXI of 1860) (IN) 2015-08-12 EP claimed
WO-2014057500-A1 ONE STEP PROCESS FOR SYNTHESIS OF CYCLIC CARBONATES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED (IN) 2014-04-17 WO claimed
EP-4696696-A1 IMMOBILIZED QUATERNARY PHOSPHONIUM SALT HAVING PHENOL DOMAIN, METHOD FOR PRODUCING SAME, AND CYCLIC CARBONATE PRODUCTION METHOD USING SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-02-18 EP disclosed
US-20250381557-A1 IMMOBILIZED ZINC COMPLEX HAVING GUANIDINE LIGAND, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CYCLIC CARBONATE USING SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-12-18 US disclosed
EP-4545543-A1 IMMOBILIZED ZINC COMPLEX HAVING GUANIDINE LIGAND, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CYCLIC CARBONATE USING SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-04-30 EP disclosed
WO-2024214491-A1 IMMOBILIZED QUATERNARY PHOSPHONIUM SALT HAVING PHENOL DOMAIN, METHOD FOR PRODUCING SAME, AND CYCLIC CARBONATE PRODUCTION METHOD USING SAME 信越化学工業株式会社 2024-10-17 WO disclosed
US-12107222-B2 Liquid electrolyte comprising organic carbonates and cyclic sulfoxides for applications in lithium secondary batteries FORSCHUNGSZENTRUM JUELICH GMBH (DE) 2024-10-01 US disclosed
US-20130310575-A1 METHODS AND SYSTEMS FOR THE FORMATION OF CYCLIC CARBONATES MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2013-11-21 US disclosed
US-20130310575-A1 METHODS AND SYSTEMS FOR THE FORMATION OF CYCLIC CARBONATES MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2013-11-21 US disclosed
WO-2013169362-A1 METHODS AND SYSTEMS FOR THE FORMATION OF CYCLIC CARBONATES MASSACHUSSETTS INSTITUTE OF TECHNOLOGY (US) 2013-11-14 WO disclosed
EP-1752193-A1 Use of one or more cyclic 1,2-alkylene carbonates as stabilizer and activity enhancer for preservatives, corresponding composition Dr. Straetmans Chemische Produkte GmbH (DE) 2007-02-14 EP disclosed
US-4332729-A CATALYZED CYCLIZATION THE DOW CHEMICAL COMPANY (US) 1982-06-01 US disclosed
US-4331604-A Preparation of cyclic carbonates THE DOW CHEMICAL COMPANY (US) 1982-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250381557-A1 IMMOBILIZED ZINC COMPLEX HAVING GUANIDINE LIGAND, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CYCLIC CARBONATE USING SAME CA2, GRIA1, GUCY1A2 CYP1A2 2515/4885ALDH1A1 4014/4885PPARG 3127/4885
US-20150259318-A1 ONE STEP PROCESS FOR SYNTHESIS OF CYCLIC CARBONATES CDY1; CDY1B, CA4, CCNY CYP1A2 577/4885ALDH1A1 858/4885PPARG 3613/4885
US-20130310575-A1 METHODS AND SYSTEMS FOR THE FORMATION OF CYCLIC CARBONATES CA4, CA2, CA1 CYP1A2 280/4885ALDH1A1 2354/4885PPARG 2578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.